These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38178748)

  • 21. Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.
    Dashti NK; Wehrs RN; Thomas BC; Nair A; Davila J; Buckner JC; Martinez AP; Sukov WR; Halling KC; Howe BM; Folpe AL
    Histopathology; 2018 Sep; 73(3):514-520. PubMed ID: 29758589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones.
    Koutlas IG; Olson DR; Rawwas J
    Head Neck Pathol; 2021 Mar; 15(1):374-380. PubMed ID: 32504289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
    Yang L; Zhang HJ; Yang SJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review.
    Duan FL; Yang H; Gong X; Zuo Z; Qin S; Ji J; Zhou C; Dai J; Guo P; Liu Y
    Histopathology; 2023 Feb; 82(3):478-484. PubMed ID: 36350070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma-diagnostic challenge and report of two cases.
    Carrillo-Ng H; Liang Y; Chang S; Afkhami M; Gernon T; Bell D; Arias-Stella JA
    Genes Chromosomes Cancer; 2023 Jul; 62(7):430-436. PubMed ID: 37057803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spindle cell rhabdomyosarcoma in a lumbar vertebra with FUS-TFCP2 fusion.
    Tagami Y; Sugita S; Kubo T; Iesato N; Emori M; Takada K; Tsujiwaki M; Segawa K; Sugawara T; Kikuchi T; Hasegawa T
    Pathol Res Pract; 2019 Aug; 215(8):152399. PubMed ID: 30948206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Intraosseous Spindle Cell Rhabdomyosarcoma: A Case Report in an Unusual Location.
    Plotzke JM; Rabah R; Robinson DR; Edmonds A; Bloom DA; Mody R; Heider A
    Pediatr Dev Pathol; 2024 Jun; ():10935266241257547. PubMed ID: 38845135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype.
    Trecourt A; Macagno N; Ngo C; Philip CA; Lopez J; Ferreira J; Alves-Vale C; Ray-Coquard I; Genestie C; Agaimy A; Devouassoux-Shisheboran M
    Virchows Arch; 2023 Jun; 482(6):967-974. PubMed ID: 37097347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
    Warmke LM; Meis JM
    Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection.
    Demirkesen C; Danyeli AE; Yıldız P; Ertekin SS; Yılmaz B; Karahan Sİ; Bahrami A
    J Cutan Pathol; 2023 Dec; 50(12):1059-1064. PubMed ID: 37669767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
    Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
    Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers.
    Michal M; Rubin BP; Agaimy A; Kosemehmetoglu K; Rudzinski ER; Linos K; John I; Gatalica Z; Davis JL; Liu YJ; McKenney JK; Billings SD; Švajdler M; Koshyk O; Kinkor Z; Michalová K; Kalmykova AV; Yusifli Z; Ptáková N; Hájková V; Grossman P; Šteiner P; Michal M
    Mod Pathol; 2021 Apr; 34(4):770-785. PubMed ID: 33012788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases.
    Shibayama T; Shimoi T; Mori T; Noguchi E; Honma Y; Hijioka S; Yoshida M; Ogawa C; Yonemori K; Yatabe Y; Yoshida A
    Am J Surg Pathol; 2022 Jan; 46(1):134-146. PubMed ID: 34049318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.
    Diaz-Perez JA; Nielsen GP; Antonescu C; Taylor MS; Lozano-Calderon SA; Rosenberg AE
    Hum Pathol; 2019 Aug; 90():45-53. PubMed ID: 31078563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [EWSR1-SMAD3 positive fibroblastic tumor: a clinicopathological analysis].
    Su HY; Zhao L; Ji G; Yao QL; Bai QM; Zhou XY; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):19-24. PubMed ID: 36617901
    [No Abstract]   [Full Text] [Related]  

  • 37. Sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases.
    Dehner CA; Torres-Mora J; Gupta S; Kipp BR; Halling KC; Chen S; Warmke LM; Michal M; Alani A; Yu W; Kovacs K; Obeidin F; Iwenofu OH; Satturwar S; Meis JM; Folpe AL
    Mod Pathol; 2024 Feb; 37(2):100400. PubMed ID: 38043789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraosseous Spindle Cell/Epithelioid Rhabdomyosarcoma with
    Valério E; Furtado Costa JL; Perez Fraile NM; Credidio CH; Taveira Garcia MR; Neto CS; Costa FD
    Int J Surg Pathol; 2023 Aug; 31(5):861-865. PubMed ID: 36474403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones.
    Silva Cunha JL; Cavalcante IL; da Silva Barros CC; Alves PM; Nonaka CFW; Albuquerque AFM; de Almeida OP; de Andrade BAB; Cavalcante RB
    Oral Oncol; 2022 Jul; 130():105876. PubMed ID: 35550988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas.
    Panferova A; Sinichenkova KY; Abu Jabal M; Usman N; Sharlai A; Roshchin V; Konovalov D; Druy A
    Cold Spring Harb Mol Case Stud; 2022 Jun; 8(5):. PubMed ID: 35768243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.